The expression of NR3C2 in CRC tumours and paired paracancerous tissues of 71 CRC patients and five CRC cell lines was detected by western blotting, immunohistochemistry and real‐time reverse‐transcription PCR. This evidence concerns the gene NR3C2 and colorectal carcinoma.